Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreatic Cancer: BRCA Targeted Therapy and Beyond. | Cancers (Basel) | 2023 | 37296917 | PubTator, text mining | PubMed |
| Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges. | Cancers (Basel) | 2023 | 37296848 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency Score Determined by Genomic Instability in a Romanian Cohort. | Diagnostics (Basel) | 2023 | 37296748 | PubTator, text mining | PubMed |
| A study of clinical and molecular characteristics in bilateral primary breast cancer. | Cancer Med | 2023 | 37293877 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia. | Blood Cancer J | 2023 | 37286545 | PubTator, text mining | PubMed |
| Mismatch repair gene germline mutations in patients with prostate cancer. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37283096 | PubTator, text mining | PubMed |
| Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. | Nat Med | 2023 | 37277454 | PubTator, text mining | PubMed |
| Expression profiles and potential roles of serum tRNA‑derived fragments in diabetic nephropathy. | Exp Ther Med | 2023 | 37273759 | PubTator, text mining | PubMed |
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers. | Clin Epigenetics | 2023 | 37270516 | PubTator, text mining | PubMed |
| PARP Inhibitors in Ovarian Cancer: A Review. | Target Oncol | 2023 | 37268756 | PubTator, text mining | PubMed |
| Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer. | Breast Care (Basel) | 2023 | 37261134 | PubTator, text mining | PubMed |
| Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer. | Oncoimmunology | 2023 | 37261085 | PubTator, text mining | PubMed |
| Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines. | Br J Cancer | 2023 | 37258796 | PubTator, text mining | PubMed |
| HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients. | NPJ Precis Oncol | 2023 | 37258600 | PubTator, text mining | PubMed |
| Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C. | Cancer Res | 2023 | 37253112 | PubTator, text mining | PubMed |
| Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy. | Front Oncol | 2023 | 37251919 | PubTator, text mining | PubMed |
| Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240284 | PubTator, text mining | PubMed |
| DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC. | Int J Mol Sci | 2023 | 37240218 | PubTator, text mining | PubMed |
| Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA Breaks. | Int J Mol Sci | 2023 | 37240063 | PubTator, text mining | PubMed |
| Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. | Int J Mol Sci | 2023 | 37239898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=25